Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline <scp> HbA <sub>1c</sub> </scp>
CGM represents a cost-effective intervention for Chinese adults with uncontrolled T2D, demonstrating enhanced economic value in populations with elevated baseline HbA<sub>1c</sub> levels. Implementing risk-stratified reimbursement policies coupled with price negotiations aligned with evidence-based cost thresholds ($1920-$2316 annually), may optimize healthcare resource allocation.
Authors
- Han-Biao Wu
- Yuan Fang (ORCID: https://orcid.org/0000-0003-3903-6011)
- Zhi-Kun Qiu (ORCID: https://orcid.org/0000-0003-3463-8750)
- Yubing Ye
- Jisheng Chen (ORCID: https://orcid.org/0009-0007-4807-8017)
- Xiaoning Zhang (ORCID: https://orcid.org/0000-0002-8474-9785)
- Li Hu (ORCID: https://orcid.org/0000-0002-5040-4076)
- Chang‐Sheng Wang (ORCID: https://orcid.org/0000-0002-4970-0636)
- Sha Lai (ORCID: https://orcid.org/0009-0005-2214-5678)
- Guangxin Han
Institutions
- Guangdong Pharmaceutical University (CN)
- Nanfang Hospital (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1111/dom.70333
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- University of Oxford
- National Key Clinical Specialty Discipline Construction Program of China